FOXP3 and melanoma: On the other hand, studies assessing T regs under PD-1/PD-L1 blockade show a distinct downregulation of FoxP3 for melanoma (31) while in gliomas exhausted T regs with high expression of PD-1 failing to suppress effector T cell proliferation accumulated (32).